Cargando…

Extreme hepatectomy with modified ALPPS in a rat model: gradual portal vein restriction associated with hepatic artery restriction

BACKGROUND & AIM: Associating liver partition and portal vein ligation (PVL) for staged hepatectomy (ALPPS) is a creative strategy for enlarging the future liver remnant (FLR) and increasing the tumor resectability rate. However, the indications for ALPPS must have a certain limit when the FLR i...

Descripción completa

Detalles Bibliográficos
Autores principales: He, Xiaoqin, Zhang, Yuefeng, Ma, Peng, Mou, Zuo, Wang, Wei, Yu, Kaihuan, Wang, Weixing
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10521515/
https://www.ncbi.nlm.nih.gov/pubmed/37749572
http://dx.doi.org/10.1186/s12893-023-02197-y
_version_ 1785110144603914240
author He, Xiaoqin
Zhang, Yuefeng
Ma, Peng
Mou, Zuo
Wang, Wei
Yu, Kaihuan
Wang, Weixing
author_facet He, Xiaoqin
Zhang, Yuefeng
Ma, Peng
Mou, Zuo
Wang, Wei
Yu, Kaihuan
Wang, Weixing
author_sort He, Xiaoqin
collection PubMed
description BACKGROUND & AIM: Associating liver partition and portal vein ligation (PVL) for staged hepatectomy (ALPPS) is a creative strategy for enlarging the future liver remnant (FLR) and increasing the tumor resectability rate. However, the indications for ALPPS must have a certain limit when the FLR is too small. We aimed to establish a modified ALPPS model with more widen applicability in rats. METHODS: An extreme ALPPS model was established in rodents with only a 6.5% FLR. The portal vein (PV) was subjected to restriction to different degrees, then the portal vein pressure (PVP) was measured. Then, different modifications of ALPPS, including hepatic artery restriction (HAR), gradual portal vein restriction (GPVR), and GPVR-associated HAR (HAR+GPVR), were applied in the extreme ALPPS models. RESULTS: PVL or PVR provoked an immediate increase in the PVP. The PVP in the PVR -1.28 mm, PVR -0.81 mm, PVR -0.63 mm, and PVL groups was 11.05±1.57 cmH(2)O, 16.18±1.92 cmH(2)O, 20.66±1.99 cmH(2)O, and 24.10±3.33 cmH(2)O, respectively, and the corresponding 3-day survival rate was 100%, 90.09%, 36.33% and 0, respectively. Then, in the extreme ALPPS model, the growth ratio of the FLR in the control, HAR, GPVR, and HAR+GPVR groups was 0.43±0.21, 0.50±0.16, 4.80±0.86, and 7.40±2.56, and as a consequence, the corresponding 30-day survival rate was 9.09%, 15.38%, 84.61% and 92.90%, respectively. CONCLUSION: ALPPS itself has a limit, and high PVP after PVL contributes to postoperative death in the extreme ALPPS model. Furthermore, a modified method for extreme ALPPS is proposed, i.e., GPVR+HAR in place of PVL, which significantly improves the survival rate of extreme hepatectomy in rat models. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s12893-023-02197-y.
format Online
Article
Text
id pubmed-10521515
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-105215152023-09-27 Extreme hepatectomy with modified ALPPS in a rat model: gradual portal vein restriction associated with hepatic artery restriction He, Xiaoqin Zhang, Yuefeng Ma, Peng Mou, Zuo Wang, Wei Yu, Kaihuan Wang, Weixing BMC Surg Research BACKGROUND & AIM: Associating liver partition and portal vein ligation (PVL) for staged hepatectomy (ALPPS) is a creative strategy for enlarging the future liver remnant (FLR) and increasing the tumor resectability rate. However, the indications for ALPPS must have a certain limit when the FLR is too small. We aimed to establish a modified ALPPS model with more widen applicability in rats. METHODS: An extreme ALPPS model was established in rodents with only a 6.5% FLR. The portal vein (PV) was subjected to restriction to different degrees, then the portal vein pressure (PVP) was measured. Then, different modifications of ALPPS, including hepatic artery restriction (HAR), gradual portal vein restriction (GPVR), and GPVR-associated HAR (HAR+GPVR), were applied in the extreme ALPPS models. RESULTS: PVL or PVR provoked an immediate increase in the PVP. The PVP in the PVR -1.28 mm, PVR -0.81 mm, PVR -0.63 mm, and PVL groups was 11.05±1.57 cmH(2)O, 16.18±1.92 cmH(2)O, 20.66±1.99 cmH(2)O, and 24.10±3.33 cmH(2)O, respectively, and the corresponding 3-day survival rate was 100%, 90.09%, 36.33% and 0, respectively. Then, in the extreme ALPPS model, the growth ratio of the FLR in the control, HAR, GPVR, and HAR+GPVR groups was 0.43±0.21, 0.50±0.16, 4.80±0.86, and 7.40±2.56, and as a consequence, the corresponding 30-day survival rate was 9.09%, 15.38%, 84.61% and 92.90%, respectively. CONCLUSION: ALPPS itself has a limit, and high PVP after PVL contributes to postoperative death in the extreme ALPPS model. Furthermore, a modified method for extreme ALPPS is proposed, i.e., GPVR+HAR in place of PVL, which significantly improves the survival rate of extreme hepatectomy in rat models. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s12893-023-02197-y. BioMed Central 2023-09-25 /pmc/articles/PMC10521515/ /pubmed/37749572 http://dx.doi.org/10.1186/s12893-023-02197-y Text en © The Author(s) 2023 https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
spellingShingle Research
He, Xiaoqin
Zhang, Yuefeng
Ma, Peng
Mou, Zuo
Wang, Wei
Yu, Kaihuan
Wang, Weixing
Extreme hepatectomy with modified ALPPS in a rat model: gradual portal vein restriction associated with hepatic artery restriction
title Extreme hepatectomy with modified ALPPS in a rat model: gradual portal vein restriction associated with hepatic artery restriction
title_full Extreme hepatectomy with modified ALPPS in a rat model: gradual portal vein restriction associated with hepatic artery restriction
title_fullStr Extreme hepatectomy with modified ALPPS in a rat model: gradual portal vein restriction associated with hepatic artery restriction
title_full_unstemmed Extreme hepatectomy with modified ALPPS in a rat model: gradual portal vein restriction associated with hepatic artery restriction
title_short Extreme hepatectomy with modified ALPPS in a rat model: gradual portal vein restriction associated with hepatic artery restriction
title_sort extreme hepatectomy with modified alpps in a rat model: gradual portal vein restriction associated with hepatic artery restriction
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10521515/
https://www.ncbi.nlm.nih.gov/pubmed/37749572
http://dx.doi.org/10.1186/s12893-023-02197-y
work_keys_str_mv AT hexiaoqin extremehepatectomywithmodifiedalppsinaratmodelgradualportalveinrestrictionassociatedwithhepaticarteryrestriction
AT zhangyuefeng extremehepatectomywithmodifiedalppsinaratmodelgradualportalveinrestrictionassociatedwithhepaticarteryrestriction
AT mapeng extremehepatectomywithmodifiedalppsinaratmodelgradualportalveinrestrictionassociatedwithhepaticarteryrestriction
AT mouzuo extremehepatectomywithmodifiedalppsinaratmodelgradualportalveinrestrictionassociatedwithhepaticarteryrestriction
AT wangwei extremehepatectomywithmodifiedalppsinaratmodelgradualportalveinrestrictionassociatedwithhepaticarteryrestriction
AT yukaihuan extremehepatectomywithmodifiedalppsinaratmodelgradualportalveinrestrictionassociatedwithhepaticarteryrestriction
AT wangweixing extremehepatectomywithmodifiedalppsinaratmodelgradualportalveinrestrictionassociatedwithhepaticarteryrestriction